Search

Search Constraints

You searched for: Author/Creator Germing, Ulrich

Search Results

1. Dynamic assessment of RBC‐transfusion dependency improves the prognostic value of the revised‐IPSS in MDS patients. Issue 6 (20th March 2017)

3. Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study. Issue 10 (October 2017)

4. Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT. (2nd February 2017)

6. Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes. Issue 1 (January 2020)

8. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy. Issue 6 (3rd June 2016)

9. Acute myeloid leukemia‐induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells. (20th May 2021)

10. Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center. (September 2021)